As TNFα is a key regulator of phenotypic plasticity in melanoma cells, it is tempting to speculate that the removal of TNFα or modulation of this pathway may divert melanoma cells from a dedifferentiated drug resistant state, and resensitize melanomas to therapies. This evidence concerns the gene TNF and melanoma.